Himalaya Nutravedics, a company in the Pharmaceuticals industry, reported revenue of ₹27 crore and net profit of ₹4.44 crore for the September 2026 quarter.
Himalaya Nutravedics (BSE: HNIL) closed at ₹170.00 on 20 Nov 2026. Its market capitalisation is ₹150 crore and it trades at 17.9 times earnings.
Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.